Michelle Zanoni1, Rodrigo Cortes1, Ricardo S Diaz1,6, M Cecilia Sucupira1, Denise Ferreira,7, Lilian A Inocencio,7 Cintia Vilhena1,6, Clive Loveday2, RM Lloyd Jr3, M Holodniy. Comparative Effectiveness of Dried Plasma HIV-1 Viral Load Testing in Brazil Using ViveST™ for Sample Collection. Journal of Clinical Virology (2010) Article in Press
R. M. Lloyd, Jr., D. A. Burns, J. T. Huong, R. L. Mathis, M. A. Winters, M. Tanner, A. De La Rosa, B. Yen-Lieberman, W. Armstrong, A. Taege, D. R. McClernon, J. L. Wetshtein, Brian M. Friedrich, Monique R. Ferguson, William O’Brien, P. M. Feorino, and M. Holodniy. Dried-Plasma Transport Using a Novel Matrix and Collection System or Human Immunodeficiency Virus and Hepatitis C Virus Virologic Testing. Journal of Clinical Microbiology, 2009 May;47(5):1491-6. Epub 2009 Mar 25.
Kagen, R.M. Lee, T.-S, Ross, L., Lloyd Jr R.M., Lewinski, M.A. and Potts, S.J. Molecular Basis of Antagonism Between K70E and K65R Tenofovir-Associated Mutations in HIV-1 Reverse Transcriptase. Antiviral Res. 2007 Sep;75(3):210-8. Epub 2007 Apr 4
Grant RM, Kuritzkes, DR, Johnson, VA, Mellors, JW, Sullivan, JL, Swanstrom, R, D’Aquila, RT, Gorder, MV, Holodniy, M, Lloyd RM Jr,. Aquila RD, Reid C, Morgan GF, and Winslow DL. Accuracy of the TRUGENE HIV-1 Genotyping Kit. Journal Clinical Microbiology Apr. (2003) p.1586-1593
Kuritzkes, DR, Grant, RM, Feorino, PM, Griswold, M, Hoover, M, Young, R, Day, S, Lloyd, RM JR, Reid, C, Morgan, GF, and Winslow, DL. Performance Characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System. Journal Clinical Microbiology Apr. (2003) p.1594-1599
Parker MM, Wade N, Lloyd RM JR, Birkhead GS, Gallagher BK, Chehu B, Sullivan T, and Taylor J. Prevalence of Genotypic Drug Resistance in a Cohort of HIV-Infected Newborns. J AIDS (2003) 32(3): 292-297
Kantor R, Mutetwa S, Zijenah LS, Shafer, RW, Mutetwa, S, Johnston E, Lloyd RM JR, Von Lieven A, Israelski D, and Katzenstein, DA. HIV-1 Subtype “C” Reverse Transcriptase and Protease Genotypes in Zimbabwe Patients Failing Antiretroviral Therapy AIDS Research and Human Retroviruses 2002 18:18 1407-1413
Haas DW, Clough LA., Johnson, BW Harris VL, Spearman P. Wilkinson GR, Fletcher CV. Fiscus S., Raffanti S., Donlon, R., McKinsey J. Nicotera J. Schmidt D., Shoup RE., Kates RE., Lloyd RM Jr., Larder B. Evidence of source of HIV type 1 within the central nervous system by ultra-intensive sampling of cerebrospinal fluid and plasma. AIDS Res Hum Retroviruses. 2000 Oct. 10;16(15):1491-1502.
Tang Yi-Wei., Huong J., Lloyd R.M. Jr., Spearman, Paul., and Haas, David W., Comparison of Human Immunodeficiency Virus Type 1 RNA Sequence Heterogeneity in Cerebrospinal Fluid and Plasma. Journal Clinical Microbiology. 2000 Dec; 38(12):4637-4639
Smith R. A., Remington K.M., Lloyd Jr. R.M., Schinazi R.F., and North T.W., A Novel Point Mutation at Position 156 of Reverse Transcriptase from Feline Immunodeficiency Virus Confers Resistance to the Combination of (-)-ß-L-2’,3’-dideoxy-3’-thiacytidine and 3’-azido-3’-deoxythymidine. Proc. Natl. Acad. Sci. USA. 82:1783-1790 (1997)
Smith R. A., Remington K.M., Lloyd Jr. R.M., Schinazi R.F., and North T.W., A Novel Met to Thr Mutation in the YMDD Motif of Reverse Transcriptase from Feline Immunodeficiency Virus Confers Resistance to Oxathiolane Nucleosides. Journal of Virology 71: 2357- 2362 (1997)
Lesnikowski Z. J., Fulcrand G., Lloyd Jr. R. M., Juodawlkis A., Schinazi R. F., Carboranyl Oligonucleotides. 3. Biochemical Properties of Oligonucleotides Containing 5-(o-Carboran-1-yl)-2′-deoxyuridine. Biochemistry 35: 5741-5746 (1996)
Lesnikowski Z. J., Juodawlkis A. S., Lloyd Jr. R. M., Chunk C. K., Schinazi R. F., Synthesis and Anti-HIV-1 Reverse Transcriptase Activity of Triphosphates of Penciclovir and ß-D-Dioxolane-Guanine. Phosphorus, Sulfur, and Silicon 111: 83 (1996)
Lesnikowski Z. J., Fulcrand G., Juodawlkis A., Lloyd Jr. R. M., Schinazi R. F., Biological Properties of Dodeca(thymidine Phosphates) Containing 5-(o-Carboran-1-yl)-2′-Deoxyuridine. Phosphorus, Sulfur, and Silicon 109-110: 385-388 (1996)
Bonafonte, Maria-Teresa.,Lloyd, R.M. Jr., Garmon, D. K., You, Xiangdong., Arrowood, Michael J., Schinazi Raymond F., and Mead J.R.,Cloning and Expression of Sporozoite and Oocyst Cryptosporidium parvum Recombinant Proteins.Journal of Eukaryotic Microbiology. Vol 43, No 5(1996)
Schinazi R. F., Lloyd Jr. R.M., Ramanathan, C.S. Taylor, E.W., Antiviral Drug Resistance mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Occur in Specific RNA Structural Regions. Antimicrobial Agents and Chemotherapy 38: 268-274 (1994)
Mead JR, Lloyd RM Jr, You X, Tucker-Burden C., Arrowood MJ, and Schinazi RF. Isolation and partial characterization of Cryptosporidium sporozoite and oocyst wall recombinant proteins. Journal Eukaryote Microbiology. 1994 sep-Oct:41(5):51S
Kattan, Geraldine, Fulcrand-El,., Zbigniew J., Lesnikowski, Shijie Yao, Tanious, Farial., Wilson, David W., and Schinazi Raymond F., Carboranyl Oligonucleotides. 2. Synthesis and Physiochemical Properties of Dodecathymidylate Containing 5-( o-Carboran-1-yl)-2’-deoxyuridine. Journal of the American Chemical Society (1994), 16.
Schinazi R. F., Lloyd Jr, R. M., Nguyen M., Cannon D., McMillan A., Ilksoy N., Chu C., Liotta D.C., Bazmi H., Mellors J., Characterization of Human Immunodeficiency Viruses Resistant to Oxathiolane-Cytosine Nucleosides. Antimicrobial Agents and Chemotherapy 37: 875-881 (1993)
Schinazi R.F., McMillan A., Cannon C., Mathis R., Lloyd Jr. R.M., Peck A., Sommadossi J-P., Clair M., Wilson J., Furman P.A., Painter G., Choi W.,Liotta D. Selective Inhibition of Human Immunodeficiency Viruses by Racemates and Enantiomers of cis-5-Fluoro-1-[2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl] Cytosine. Antimicrobial Agents and Chemotherapy 36: 2423-2431 (1992)
Schinazi R.F., Lloyd R.,Oswald B., Manning C. Effects of AZT, AzddU, FDT, and BCH-189 Nucleosides on DNA Chain Terminations Mediated by HIV-1 Reverse Transcriptase. Antiviral Research 15: supplement 1 (1991)